Study of a Human Bispecific Antibody VRC-HIVMAB0121-00-AB (CAP256J3LS) Administered Intravenously or Subcutaneously to Healthy Adults

NCT06585891 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

24

Enrollment

NIH

Sponsor class

Conditions

HIV Infection

Interventions

BIOLOGICAL: VRC-HIVMAB0121-00-AB

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)